Towerpoint Wealth’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-664
Closed -$209K – 119
2026
Q2
$209K Buy
664
+4
+0.6% +$1.26K 0.07% 111
2026
Q1
$217K Sell
660
-34
-5% -$12.2K 0.09% 89
2025
Q4
$244K Sell
694
-11
-2% -$4.01K 0.1% 85
2025
Q3
$261K Sell
705
-13
-2% -$5.02K 0.11% 78
2025
Q2
$284K Buy
718
+43
+6% +$16.1K 0.13% 76
2025
Q1
$251K Sell
675
-39
-5% -$14.8K 0.12% 71
2024
Q4
$257K Sell
714
-2
-0.3% -$741 0.13% 74
2024
Q3
$259K Sell
716
-4
-0.6% -$1.38K 0.12% 73
2024
Q2
$245K Buy
720
+56
+8% +$19K 0.12% 71
2024
Q1
$238K Buy
+664
New +$223K 0.12% 70
2023
Q3
– Sell
-667
Closed -$203K – 82
2023
Q2
$203K Buy
+667
New +$193K 0.11% 82

Other funds holding SYK

Towerpoint Wealth's SYK Position: Q3 2026 in Review

Towerpoint Wealth sold out of Stryker (SYK) in Q3 2026, closing a stake of 664 shares — an estimated $209K sold.

Towerpoint Wealth first reported a position in SYK in Q2 2023 and held it in 11 quarters. The position peaked at $284K in Q2 2025. 875 funds tracked by Wall St. Rank hold SYK as of Q3 2026.

  • Towerpoint Wealth reported no remaining Stryker position as of Q3 2026 after selling out during the quarter.
  • Towerpoint Wealth sold 664 Stryker shares in Q3 2026, an estimated $209K.
  • Towerpoint Wealth first reported a position in Stryker in Q2 2023 and held it in 11 quarters.
  • Towerpoint Wealth's Stryker position peaked at $284K in Q2 2025.
  • 875 funds tracked by Wall St. Rank held Stryker as of Q3 2026.

Based on Towerpoint Wealth's 13F filing for Q3 2026, filed 13 Oct 2026.